From the Department of Radiology (M.M.-B.), University of North Carolina, Chapel Hill, North Carolina
Department of Radiology (M.M.-B., C.Z.), University of Washington, Seattle, Washington.
AJNR Am J Neuroradiol. 2022 Jul;43(7):951-957. doi: 10.3174/ajnr.A7541. Epub 2022 Jun 16.
Intracranial vessel wall MR imaging is an emerging technique for intracranial vasculopathy assessment. Our aim was to investigate intracranial vessel wall MR imaging use by the American Society of Neuroradiology (ASNR) members at their home institutions, including indications and barriers to implementation.
The ASNR Vessel Wall Imaging Study Group survey on vessel wall MR imaging use, frequency, applications, MR imaging systems and field strength used, protocol development approaches, vendor engagement, reasons for not using vessel wall MR imaging, ordering-provider interest, and impact on clinical care, was distributed to the ASNR membership between April 2 and August 30, 2019.
There were 532 responses; 79 were excluded due to nonresponse and 42 due to redundant institutional responses, leaving 411 responses. Fifty-two percent indicated that their institution performs vessel wall MR imaging, with 71.5% performed at least 1-2 times/month, most frequently on 3T MR imaging, and 87.7% using 3D sequences. Protocols most commonly included were T1-weighted pre- and postcontrast and TOF-MRA; 60.6% had limited contributions from vendors or were still in protocol development. Vasculopathy differentiation (94.4%), cryptogenic stroke (41.3%), aneurysm (38.0%), and atherosclerosis (37.6%) evaluation were the most common indications. For those not performing vessel wall MR imaging, interpretation (53.1%) or technical (46.4%) expertise, knowledge of applications (50.5%), or limitations of clinician (56.7%) or radiologist (49.0%) interest were the most common reasons. If technical/expertise obstacles were overcome, 56.4% of those not performing vessel wall MR imaging indicated that they would perform it. Ordering providers most frequently inquiring about vessel wall MR imaging were from stroke neurology (56.5%) and neurosurgery (25.1%), while 34.3% indicated that no providers had inquired.
More than 50% of neuroradiology groups use vessel wall MR imaging for intracranial vasculopathy characterization and differentiation, emphasizing the need for additional technical and educational support, especially as clinical vessel wall MR imaging implementation continues to grow.
颅内血管壁磁共振成像(intracranial vessel wall MR imaging)是一种用于颅内血管病变评估的新兴技术。我们的目的是研究美国神经放射学会(ASNR)成员在其所在机构中使用颅内血管壁磁共振成像的情况,包括实施的适应证和障碍。
2019 年 4 月 2 日至 8 月 30 日,向 ASNR 血管壁成像研究组的成员分发了关于血管壁磁共振成像使用情况、频率、应用、使用的磁共振成像系统和场强、协议制定方法、供应商参与情况、不使用血管壁磁共振成像的原因、开单医生的兴趣以及对临床护理的影响的调查。
共收到 532 份回复,其中 79 份因未回复而被排除,42 份因重复的机构回复而被排除,最终有 411 份回复。52%的人表示其所在机构进行血管壁磁共振成像,71.5%的机构每月至少进行 1-2 次检查,最常使用 3T 磁共振成像,87.7%的机构使用 3D 序列。最常包含的协议是 T1 加权前后对比和 TOF-MRA;60.6%的机构依赖供应商的支持有限或仍在制定协议。血管病变鉴别(94.4%)、不明原因卒中(41.3%)、动脉瘤(38.0%)和动脉粥样硬化(37.6%)评估是最常见的适应证。对于不进行血管壁磁共振成像的机构,解释(53.1%)或技术(46.4%)专业知识、对应用的了解(50.5%)、临床医生(56.7%)或放射科医生(49.0%)兴趣的限制是最常见的原因。如果克服了技术/专业知识方面的障碍,56.4%的不进行血管壁磁共振成像的机构表示会进行此项检查。询问血管壁磁共振成像的开单医生最常来自卒中神经病学(56.5%)和神经外科(25.1%),而 34.3%的机构表示没有医生询问过。
超过 50%的神经放射学团队使用颅内血管壁磁共振成像来描述和区分颅内血管病变,这强调了需要更多的技术和教育支持,尤其是随着临床血管壁磁共振成像的应用不断增加。